192 related articles for article (PubMed ID: 15719373)
1. Management of midgut carcinoids.
Akerström G; Hellman P; Hessman O; Osmak L
J Surg Oncol; 2005 Mar; 89(3):161-9. PubMed ID: 15719373
[TBL] [Abstract][Full Text] [Related]
2. Midgut carcinoid tumours: surgical treatment and prognosis.
Kerström G; Hellman P; Hessman O
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):717-28. PubMed ID: 16253896
[TBL] [Abstract][Full Text] [Related]
3. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic, surgical and medical aspect of the midgut carcinoids.
de Vries H; Verschueren RC; Willemse PH; Kema IP; de Vries EG
Cancer Treat Rev; 2002 Feb; 28(1):11-25. PubMed ID: 12027412
[TBL] [Abstract][Full Text] [Related]
5. Method for dissection of mesenteric metastases in mid-gut carcinoid tumors.
Ohrvall U; Eriksson B; Juhlin C; Karacagil S; Rastad J; Hellman P; Akerström G
World J Surg; 2000 Nov; 24(11):1402-8. PubMed ID: 11038214
[TBL] [Abstract][Full Text] [Related]
6. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
[TBL] [Abstract][Full Text] [Related]
7. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.
Turner GB; Johnston BT; McCance DR; McGinty A; Watson RG; Patterson CC; Ardill JE
Gut; 2006 Nov; 55(11):1586-91. PubMed ID: 16556667
[TBL] [Abstract][Full Text] [Related]
8. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
de Herder WW
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumours of the small intestine.
Strosberg J
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):755-73. PubMed ID: 23582917
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.
Wängberg B; Westberg G; Tylén U; Tisell L; Jansson S; Nilsson O; Johansson V; Scherstén T; Ahlman H
World J Surg; 1996 Sep; 20(7):892-9; discussion 899. PubMed ID: 8678968
[TBL] [Abstract][Full Text] [Related]
11. Carcinoid tumour.
McStay MK; Caplin ME
Minerva Med; 2002 Oct; 93(5):389-401. PubMed ID: 12410171
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
[TBL] [Abstract][Full Text] [Related]
13. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors.
Makridis C; Rastad J; Oberg K; Akerström G
World J Surg; 1996 Sep; 20(7):900-6; discussion 907. PubMed ID: 8678969
[TBL] [Abstract][Full Text] [Related]
14. AACE/ACE disease state clinical review: diagnosis and management of midgut carcinoids.
Liu EH; Solorzano CC; Katznelson L; Vinik AI; Wong R; Randolph G
Endocr Pract; 2015 May; 21(5):534-545. PubMed ID: 25962092
[TBL] [Abstract][Full Text] [Related]
15. [Effective treatment of a hormonally inactive carcinoid tumour with somatostatin analogues: application of serum chromogranin-A for clinical follow-up].
Igaz P; Rácz K; Tulassay Z
Orv Hetil; 2007 Dec; 148(49):2343-6. PubMed ID: 18048114
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of carcinoid tumours of the stomach and small intestine.
Ahlman H
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S198-201. PubMed ID: 10604130
[TBL] [Abstract][Full Text] [Related]
17. Management of disseminated midgut carcinoid tumours.
Ahlman H; Wängberg B; Jansson S; Stenqvist O; Geterud K; Tylén U; Caidahl K; Scherstén T; Tisell LE
Digestion; 1991; 49(2):78-96. PubMed ID: 1724766
[TBL] [Abstract][Full Text] [Related]
18. Carcinoid syndrome: diagnosis and medical management.
van der Lely AJ; de Herder WW
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):850-60. PubMed ID: 16444370
[TBL] [Abstract][Full Text] [Related]
19. Abdominal surgery in patients with midgut carcinoid tumors.
Akerström G; Makridis C; Johansson H
Acta Oncol; 1991; 30(4):547-53. PubMed ID: 1854512
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
Ardill JE; Johnston BT; McCance DR; Eatock M
Ann Clin Biochem; 2017 Mar; 54(2):297-301. PubMed ID: 27638929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]